Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 3.419\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CCC1CCCCN1CCCNC(=O)Cn1nc(-c2ccccc2)ccc1=O
b.) O=C(COc1ccc2ccccc2c1Br)N1CCOCC1
Answer: a. CCC1CCCCN1CCCNC(=O)Cn1nc(-c2ccccc2)ccc1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1CCCCN1CCCNC(=O)Cn1nc(-c2ccccc2)ccc1=O
CCC1CCCCN1CCCNC(=O)Cn1nc(-c2ccccc2)ccc1=O
N-[3-(2-ethylpiperidin-1-yl)propyl]-2-(6-oxo-3-phenylpyridazin-1-yl)acetamide